Skeletal Targeted Radiotherapy: Phase I/II data; Phase II

By WIR Staff | May 30, 2000 | 7:00 AM GMT

In NERX’s Phase I/II trial, 18 of 40 evaluable

Read the full 91 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

Article Purchase

This article may not be distributed to non-subscribers

More Info >PURCHASE